Cargando…

Endpoints for Lymphatic Filariasis Programs

In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was...

Descripción completa

Detalles Bibliográficos
Autores principales: Grady, Caroline A., Beau de Rochars, Madsen, Direny, Abdel N., Orelus, Jean Nicolas, Wendt, Joyanna, Radday, Jeanne, Mathieu, Els, Roberts, Jacquelin M., Streit, Thomas G., Addiss, David G., Lammie, Patrick J.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725965/
https://www.ncbi.nlm.nih.gov/pubmed/17553278
http://dx.doi.org/10.3201/eid1304.061063
_version_ 1782170549888221184
author Grady, Caroline A.
Beau de Rochars, Madsen
Direny, Abdel N.
Orelus, Jean Nicolas
Wendt, Joyanna
Radday, Jeanne
Mathieu, Els
Roberts, Jacquelin M.
Streit, Thomas G.
Addiss, David G.
Lammie, Patrick J.
author_facet Grady, Caroline A.
Beau de Rochars, Madsen
Direny, Abdel N.
Orelus, Jean Nicolas
Wendt, Joyanna
Radday, Jeanne
Mathieu, Els
Roberts, Jacquelin M.
Streit, Thomas G.
Addiss, David G.
Lammie, Patrick J.
author_sort Grady, Caroline A.
collection PubMed
description In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
format Text
id pubmed-2725965
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-27259652009-09-10 Endpoints for Lymphatic Filariasis Programs Grady, Caroline A. Beau de Rochars, Madsen Direny, Abdel N. Orelus, Jean Nicolas Wendt, Joyanna Radday, Jeanne Mathieu, Els Roberts, Jacquelin M. Streit, Thomas G. Addiss, David G. Lammie, Patrick J. Emerg Infect Dis Dispatch In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs. Centers for Disease Control and Prevention 2007-04 /pmc/articles/PMC2725965/ /pubmed/17553278 http://dx.doi.org/10.3201/eid1304.061063 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Grady, Caroline A.
Beau de Rochars, Madsen
Direny, Abdel N.
Orelus, Jean Nicolas
Wendt, Joyanna
Radday, Jeanne
Mathieu, Els
Roberts, Jacquelin M.
Streit, Thomas G.
Addiss, David G.
Lammie, Patrick J.
Endpoints for Lymphatic Filariasis Programs
title Endpoints for Lymphatic Filariasis Programs
title_full Endpoints for Lymphatic Filariasis Programs
title_fullStr Endpoints for Lymphatic Filariasis Programs
title_full_unstemmed Endpoints for Lymphatic Filariasis Programs
title_short Endpoints for Lymphatic Filariasis Programs
title_sort endpoints for lymphatic filariasis programs
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2725965/
https://www.ncbi.nlm.nih.gov/pubmed/17553278
http://dx.doi.org/10.3201/eid1304.061063
work_keys_str_mv AT gradycarolinea endpointsforlymphaticfilariasisprograms
AT beauderocharsmadsen endpointsforlymphaticfilariasisprograms
AT direnyabdeln endpointsforlymphaticfilariasisprograms
AT orelusjeannicolas endpointsforlymphaticfilariasisprograms
AT wendtjoyanna endpointsforlymphaticfilariasisprograms
AT raddayjeanne endpointsforlymphaticfilariasisprograms
AT mathieuels endpointsforlymphaticfilariasisprograms
AT robertsjacquelinm endpointsforlymphaticfilariasisprograms
AT streitthomasg endpointsforlymphaticfilariasisprograms
AT addissdavidg endpointsforlymphaticfilariasisprograms
AT lammiepatrickj endpointsforlymphaticfilariasisprograms